Current CFRI-Funded Cystic Fibrosis Researchers
2024 – 2026
Elizabeth Nash Memorial Fellowship Program
Steven Jonas, MD, PhD, Principal Investigator
Ruby Sims, PhD, Postdoctoral Fellow
University of California Los Angeles
Designing a cystic fibrosis gene therapy nanocarrier platform to target and modify airway stem cell-derived ionocytes
Ron Kopito, PhD, Principal Investigator
Celeste Riepe, PhD, Postdoctoral Fellow
Stanford University
Pharmacogenomic discovery of therapeutic targets for corrector-resistant cystic fibrosis
New Horizons Program
Daria Van Tyne, PhD, Principal Investigator
University of Pittsburgh
Optimization of activity and improved delivery of bacteriophages targeting Burkholderia spp
Feng Yuan, PhD, Principal Investigator
University of Alabama at Birmingham
Dissecting Pulmonary ionocyte subtypes and their functional roles in cystic fibrosis
2023 – 2025
Elizabeth Nash Memorial Fellowship Program
Matthew Porteus, MD, PhD, Principal Investigator
Anais Amaya Colina, PhD, Postdoctoral Fellow
Stanford University
A Hybrid Gene Correction Strategy for Cystic Fibrosis
New Horizons Program
Nadia Ameen, MD, Principal Investigator
Yale University School of Medicine
Elucidating the ion transport functions of CFTR High Expresser Cells (CHEs) and its relevance to intestinal disease in Cystic Fibrosis (CF)
Benjamin Chan, PhD, Principal Investigator
Yale University School of Medicine
Optimization of Phage Therapy to Reduce Pseudomonas-Induced Inflammation in Cystic Fibrosis
Katrine Whiteson, PhD, Principal Investigator
University of California Irvine
Targeting recalcitrant CF pathogens with phages, antibiotics, and small molecule adjuvants
Special Circumstances Grant
Beate Illek, PhD, Principal Investigator
University of California San Diego
CFTR mRNA delivery to CF airways
2022 – 2024
Elizabeth Nash Memorial Fellowship Program
Paul Bollyky, MD, PhD, Principal Investigator
Kevin Qingquan Chen, PhD, Postdoctoral Fellow
Stanford University
Targeting Bacterial Resistance to Phage Therapy in Cystic Fibrosis
New Horizons Program
Carlos Milla, MD, Principal Investigator
Stanford University
Improving CF Airway Mucociliary Clearance: Toward Transition from Animals to Humans
Kenichi Okuda, MD, PhD, Principal Investigator
University of North Carolina at Chapel Hill.
Pathways Maintaining Basal Mucin and CFTR-mediated Fluid Secretion in the Human Distal Airway
Zachary Sellers, MD, PhD, Principal Investigator
Stanford University
Targeting IRBIT to Correct Bicarbonate Secretory Defects in Cystic Fibrosis